DENVER — Nerivio, a noninvasive digital therapeutic device, provided migraine pain relief within 2 hours in 67% of adults and 71% of adolescents, Alon Ironi said at the American Headache Society’s annual scientific meeting.
“We have shown persistent efficacy over a long time, and we have demonstrated real-world efficacy in thousands of patients,” Ironi, CEO and co-founder of device manufacturer Theranica, said. “We’re moving forward with our clinical development, and we’re working on expanding the review to the preventive treatment of migraine. This is